Faecal microbiota transplantation

also known as FMT

Developed for: cirrhosis of liver · ankylosing spondylitis · Crohn disease · psoriatic arthritis · ulcerative colitis
Investigated by: Odense University Hospital · Aalborg University · Aalborg University Hospital · Aarhus University Hospital · Esbjerg Hospital - University Hospital of Southern Denmark · Hvidovre University Hospital
+6 more
· King's College Hospital NHS Trust · King's College London · Region of Southern Denmark · Sjælland University Hospital · University of Aarhus · University of Southern Denmark

2018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 21 trial
Phase 2	NCT04924270	Dec 2023 → Mar 2027 expected	Crohn disease, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis	Odense University Hospital	Recruiting	No outcome recorded
Phase 2/31 trial
Phase 2/3	NCT04932577	Jul 2021 → May 2026 overdue	cirrhosis of liver	University of Aarhus	Recruiting	No outcome recorded
Phase 31 trial
Phase 3	NCT02862249	Mar 2018 → Sep 2019	cirrhosis of liver	King's College London	Completed	No outcome recorded

Every value below carries the sentence it was read from. 3 sources stand behind the page.

Field	Value	Cited text
Known as	Faecal microbiota transplantation	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04932577 ↗ 2 NCT02862249 ↗ NCT04924270 ↗
Known as	FMT	“FMT” NCT04932577 ↗
Route	Other	“into the duodenum via a gastroscope” NCT02862249 ↗